Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study

Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study

Background: To explore the long-term safety and dynamics of the immune response induced by the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents with juvenile-onset autoimmune inflammatory rheumatic diseases (AIIRDs) compared with healthy controls. Methods: This internation...

Full description

Bibliographic Details
Main Authors: Merav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, Siman Lazauskas, Danielle Kadishevich, Efrat Ben-Nun Yaari, Adi Miller-Barmak, Yonatan Butbul Aviel, Esther Saiag, Sara Pel, Ori Elkayam, Yosef Uziel, Victoria Furer
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Vaccines
Subjects:
vaccines
COVID-19
pediatric rheumatology
juvenile-onset rheumatic diseases
safety
immunomodulatory medications
Online Access:https://www.mdpi.com/2076-393X/11/4/819

Internet

https://www.mdpi.com/2076-393X/11/4/819

Similar Items